Bulletin

Investor Alert

New York Markets Open in:

Bio-Techne Corp.

NAS: TECH

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Bio-Techne Corp.

After Hours

--Quotes are delayed by 20 min

Jan 21, 2021, 4:06 p.m.

TECH

/zigman2/quotes/203973516/composite

355.69

Change

+0.01 +0.0030%

Volume

Volume 2,437

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Previous close

$ 356.67

$ 355.68

Change

-0.99 -0.28%

Day low

Day high

$350.65

$358.41

52 week low

52 week high

$155.17

$361.47

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Bio-Techne Corp.

View Ratios

Fiscal year is July-June. All values USD millions.	2016	2017	2018	2019	2020	5-year trend
Sales/Revenue	499.02M	563M	642.99M	714.01M	738.69M
Sales Growth	-	12.82%	14.21%	11.04%	3.46%
Cost of Goods Sold (COGS) incl. D&A	180.66M	209.79M	232.5M	285.37M	282.1M
COGS excluding D&A	137.9M	149.75M	168.04M	207.2M	199.36M
Depreciation & Amortization Expense	42.76M	60.04M	64.46M	78.17M	82.74M
Depreciation	13.36M	15.61M	17.51M	19.46M	21.64M
Amortization of Intangibles	29.4M	44.43M	46.95M	58.72M	61.1M
COGS Growth	-	16.12%	10.83%	22.74%	-1.15%
Gross Income	318.36M	353.21M	410.49M	428.64M	456.59M
Gross Income Growth	-	10.95%	16.22%	4.42%	6.52%
Gross Profit Margin	-	-	-	-	61.81%	NA

	2016	2017	2018	2019	2020	5-year trend
SG&A Expense	165.01M	206.84M	249.51M	299.09M	299.58M
Research & Development	45.19M	53.51M	55.33M	62.41M	65.19M
Other SG&A	119.82M	153.33M	194.18M	236.68M	234.39M
SGA Growth	-	25.35%	20.63%	19.87%	0.16%
Other Operating Expense	-	-	-	-	-
Unusual Expense	2.76M	25.79M	24.81M	18.35M	(403,000)
EBIT after Unusual Expense	150.59M	(25.79M)	136.18M	111.19M	157.42M
Non Operating Income/Expense	(1.61M)	(1.57M)	(447,000)	21.96M	133.15M
Non-Operating Interest Income	249,000	304,000	409,000	569,000	605,000
Equity in Affiliates (Pretax)	-	-	-	-	-
Interest Expense	1.75M	7.36M	10.19M	21.71M	14.69M
Interest Expense Growth	-	321.11%	38.41%	113.04%	-32.30%
Gross Interest Expense	1.75M	7.36M	10.19M	21.71M	14.69M
Interest Capitalized	-	-	-	-	-
Pretax Income	147.48M	111.96M	125.95M	112.02M	276.48M
Pretax Income Growth	-	-24.08%	12.50%	-11.07%	146.82%
Pretax Margin	-	-	-	-	37.43%	NA
Income Tax	43.01M	35.88M	(198,000)	15.94M	47.18M
Income Tax - Current Domestic	37.76M	32.51M	33.73M	16.63M	24.99M
Income Tax - Current Foreign	7.58M	8.21M	11.98M	13.33M	8.58M
Income Tax - Deferred Domestic	1.48M	(1.87M)	(41.76M)	(10.88M)	16.13M
Income Tax - Deferred Foreign	(3.82M)	(2.98M)	(4.15M)	(3.14M)	(2.52M)
Income Tax Credits	-	-	-	-	-
Equity in Affiliates	-	-	-	-	-
Other After Tax Income (Expense)	-	(65,000)	(108,000)	(105,000)	(224,000)
Consolidated Net Income	104.48M	76.02M	126.04M	95.97M	229.07M
Minority Interest Expense	-	-	-	-	-
Net Income	104.48M	76.02M	126.04M	95.97M	229.07M
Net Income Growth	-	-27.24%	65.80%	-23.86%	138.70%
Net Margin Growth	-	-	-	-	31.01%	NA
Extraordinaries & Discontinued Operations	-	-	-	-	-
Extra Items & Gain/Loss Sale Of Assets	-	-	-	-	-
Cumulative Effect - Accounting Chg	-	-	-	-	-
Discontinued Operations	-	-	-	-	-
Net Income After Extraordinaries	104.48M	76.02M	126.04M	95.97M	229.07M
Preferred Dividends	-	-	-	-	-
Net Income Available to Common	104.48M	76.02M	126.04M	95.97M	229.07M
EPS (Basic)	2.81	2.04	3.36	2.54	6.00
EPS (Basic) Growth	-	-27.49%	65.08%	-24.48%	136.07%
Basic Shares Outstanding	37.19M	37.31M	37.48M	37.78M	38.2M
EPS (Diluted)	2.80	2.03	3.31	2.47	5.81
EPS (Diluted) Growth	-	-27.60%	63.38%	-25.50%	135.62%
Diluted Shares Outstanding	37.33M	37.5M	38.06M	38.89M	39.4M
EBITDA	196.12M	206.41M	225.45M	207.72M	239.75M
EBITDA Growth	-	5.25%	9.22%	-7.86%	15.42%
EBITDA Margin	-	-	-	-	32.46%	NA

Trending Tickers

/quotes/zigman/17636479/composite VUZI+15.60%
/quotes/zigman/237947/composite JCP-5.83%
/quotes/zigman/59392505/composite NUGT-2.93%
/quotes/zigman/59386294/composite JNUG-5.94%
/quotes/zigman/65801738/composite TLT+1.11%

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Bio-Techne Corp.

Annual Financials for Bio-Techne Corp.

Latest News

dow

nasdaq

s&p 500

Kiosk